ALZN: Alzamend Neuro, Inc. Stock

by  •  • Comments Off on ALZN: Alzamend Neuro, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.91
Enterprise Value ($M) -0.18
Book Value ($M) 3.75
Book Value / Share 0.69
Price / Book 1.04
NCAV ($M) 3.51
NCAV / Share 0.65
Price / NCAV 1.11

Profitability (mra)
Return on Invested Capital (ROIC) -1.56
Return on Assets (ROA) -7.47
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 3.80
Current Ratio 3.80

Balance Sheet (mrq) ($M)
Current Assets 4.77
Assets 5.01
Liabilities 1.25
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-12-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-09-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-07-30 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended April 30, 2024 ¨ TRANSITION REPORT PURSUANT TO SECTION
2024-03-25 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 34,165 109,965 31.07
2025-03-06 36,684 83,849 43.75
2025-03-05 17,797 82,413 21.59
2025-03-04 21,456 103,836 20.66

(click for more detail)

Similar Companies
ALGS – Aligos Therapeutics, Inc. ALTS – JanOne Inc.
ALVR – AlloVir, Inc. ANEB – Anebulo Pharmaceuticals, Inc.
ANIX – Anixa Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io